Journal of Tumor Research

Journal of Tumor Research
Open Access

ISSN: 2684-1258

Yong LIAN

Yong LIAN
He is now a doctor of the First Affiliated Hospital of Wenzhou Medical University. Young Visiting Scholar from the University of Hong Kong, Hong Kong Baptist University and Raman University. Affected by China-US relations, he landed at Wenzhou Medical University full-time in August 2021.
Wenzhou Medical University
China

Biography

15 NIH RO1 and PPG research projects totaling more than $25 million;

It has been funded by five key projects of international Cooperation and exchange of the National Natural Science Foundation of China.

? PI-3K is a key molecule in tumorigenesis, which pioneered its research and development as a target of tumor drug and the application of related drugs in clinical tumor therapy;

? Found the new function of p50 protein, and then revealed the molecular mechanism of the dual effects of arsenic carcinogenesis and cancer treatment;

? Identified the double positive feedback pathway of chronic and persistent lung inflammation in lung cancer caused by environmental carcinogens.

Research Interest

Related carcinogenic molecular mechanisms of environmental carcinogens, tumor invasion and metastasis mechanisms, and screening and identification of novel antitumor agents and their anti-tumor molecular mechanisms

Top